Antitussive effect of dextromethorphan and dextromethorphan-salbutamol combination in healthy volunteers with artificially induced cough.
The antitussive effects of dextromethorphan (30 mg) + salbutamol (2 mg), dextromethorphan (30 mg) alone and placebo on artificial cough induced by citric acid were compared in 19 healthy non-smoking volunteers in a double-blind crossover study. The method using inhaled citric acid with increasing concentrations to establish the cough threshold level showed an acceptable reproducibility and proved to be suitable for comparison of antitussive drugs. The cough threshold level was assessed before as well as 90 and 180 min after each medication. After placebo the cough threshold level showed no statistically significant rise. However, significant rises were shown following dextromethorphan (p less than 0.001) and the dextromethorphan-salbutamol combination (p less than 0.001). Between the treatments significant differences were shown in favour of the dextromethorphan-salbutamol combination. The results indicate that salbutamol has antitussive action enhancing the effect of plain dextromethorphan.
Karttunen
P
P
Remeda Pharmaceutical Co., Kuopio, Finland.
Tukiainen
H
H
Silvasti
M
M
Kolonen
S
S
D000328:Adult; D000420:Albuterol / Q000494:pharmacology*; D000996:Antitussive Agents / Q000494:pharmacology*; D002951:Citrates; D019343:Citric Acid; D003371:Cough / Q000139:chemically induced* / Q000188:drug therapy; D003915:Dextromethorphan / Q000494:pharmacology*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007981:Levorphanol / Q000031:analogs & derivatives*; D008297:Male; D010919:Placebos; D011897:Random Allocation
D000996:Antitussive Agents; D002951:Citrates; D010919:Placebos; D007981:Levorphanol; D019343:Citric Acid; D003915:Dextromethorphan; D000420:Albuterol